<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 09, 2023</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05629819</url>
  </required_header>
  <id_info>
    <org_study_id>PNS in MV patients</org_study_id>
    <nct_id>NCT05629819</nct_id>
  </id_info>
  <brief_title>Effect of Early Non-invasive Phrenic Nerve Stimulation on Weaning in Mechanically Ventilated Patients</brief_title>
  <official_title>Effect of Early Non-invasive Phrenic Nerve Stimulation on Weaning in Mechanically Ventilated Patients：A Multicenter, Randomized Controlled Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Bing Sun</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Beijing Chao Yang Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      the early application of non-invasive PNS in MV patients can increase the number of days&#xD;
      without mechanical ventilation, delay disuse phrenic atrophy, and improve the strength of&#xD;
      inspiratory muscle.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      A prospective randomized controlled study included 104 patients with MV who met inclusion&#xD;
      criteria in multiple hospital ICU units and were randomly divided 1:1 into PNS and&#xD;
      conventional groups. The PNS group received neuromuscular electrical stimulation in addition&#xD;
      to routine airway management, early activity and respiratory muscle training. It was verified&#xD;
      that early non-invasive PNS could increase the number of days without mechanical ventilation&#xD;
      for 28 days, delay disused diaphragm atrophy and improve inspiratory muscle strength.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">January 1, 2023</start_date>
  <completion_date type="Anticipated">December 31, 2024</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2024</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Single (Participant)</masking>
    <masking_description>Patients enrolled in the study were unaware of the study</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Ventilator-free days</measure>
    <time_frame>28 days</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>mechanical ventilation days</measure>
    <time_frame>28 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>re-intubation rate</measure>
    <time_frame>28 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>ICU mortality</measure>
    <time_frame>28 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>60/90-day survival rate</measure>
    <time_frame>28 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Maximal Inspiratory Pressure</measure>
    <time_frame>up to 28 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Diaphragm thickness</measure>
    <time_frame>up to 28 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>diaphragm thickening fraction</measure>
    <time_frame>up to 28 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Transdiaphragmatic Pressure</measure>
    <time_frame>up to 28 days</time_frame>
  </secondary_outcome>
  <other_outcome>
    <measure>The incidence of adverse events</measure>
    <time_frame>up to 28 days</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Medical expenses</measure>
    <time_frame>through study completion, an average of 30 days</time_frame>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">104</enrollment>
  <condition>Mechanical Ventilation</condition>
  <condition>Weaning</condition>
  <arm_group>
    <arm_group_label>PNS group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>In addition to conventional respiratory therapy and pulmonary rehabilitation, neuromuscular electrical stimulator was used for PNS&#xD;
Device Settings Strength: Maximum current tolerated by the patient (0-100mA, commonly used below 13mA) ； Stimulation time: 1.0s; Frequency: 40Hz;&#xD;
Location: The stimulation electrodes were attached to the left and right sides of the neck under the outer margin of the sternocleidomastoid muscle 1/3; The reference electrodes were attached to the surface of both pectoralis major muscles.&#xD;
Treatment frequency: 30 at a time, Bid, until withdrawal/death/for 4 weeks.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>conventional group</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>conventional respiratory therapy and pulmonary rehabilitation, including airway management, early activity, and respiratory muscle training.&#xD;
No intervention</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Non-invasive phrenic nerve stimulation</intervention_name>
    <description>Some studies have shown that PNS can relieve diaphragmatic atrophy and reverse diaphragmatic dysfunction.</description>
    <arm_group_label>PNS group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Age ≥18years and ≤80years;&#xD;
&#xD;
          -  MV time ≤48h;&#xD;
&#xD;
          -  MV duration is expected to be ≥72h;&#xD;
&#xD;
          -  The sternocleidomastoid region and pectoralis major region were completely exposed.&#xD;
&#xD;
          -  Patients or family members are willing to sign informed consent and participate in the&#xD;
             study.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  There are contraindications to PNS in vitro (Pneumothorax, active tuberculosis,&#xD;
             pleural adhesions, installation of pacemakers and defibrillators, etc.);&#xD;
&#xD;
          -  Neuromuscular disease (myasthenia gravis, etc.) or known anatomical abnormalities of&#xD;
             the diaphragm;&#xD;
&#xD;
          -  ECMO status;&#xD;
&#xD;
          -  Hemodynamic instability;&#xD;
&#xD;
          -  Uncorrected arrhythmias;&#xD;
&#xD;
          -  Be pregnant;&#xD;
&#xD;
          -  Clinical end-stage and palliative care patients.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Bing Sun, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Beijing Chao Yang Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Li Wang, B.S.Nurs</last_name>
    <phone>86015910268323</phone>
    <email>mu0mu0@yean.net</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Bing Sun, MD</last_name>
    <phone>86013911151075</phone>
    <email>ricusunbing@126.com</email>
  </overall_contact_backup>
  <verification_date>November 2022</verification_date>
  <study_first_submitted>November 11, 2022</study_first_submitted>
  <study_first_submitted_qc>November 18, 2022</study_first_submitted_qc>
  <study_first_posted type="Actual">November 29, 2022</study_first_posted>
  <last_update_submitted>November 18, 2022</last_update_submitted>
  <last_update_submitted_qc>November 18, 2022</last_update_submitted_qc>
  <last_update_posted type="Actual">November 29, 2022</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Beijing Chao Yang Hospital</investigator_affiliation>
    <investigator_full_name>Bing Sun</investigator_full_name>
    <investigator_title>professor of treatment</investigator_title>
  </responsible_party>
  <keyword>phrenic nerve stimulation</keyword>
  <keyword>diaphragm function</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

